CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
Telehealth In Clinical Trials: What Sites And Patients Think
Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.
-
Pick The Right PV Technology With Help From A Safety Data Management Expert
Otsuka's Head of U.S. GPV Safety Data Management Vikalp Khare shares how smart governance should inform pharmacovigilance (PV) technology choices.
ECOA RESOURCES
-
Whether you're looking for no-code simplicity, low-code adaptability, or fully programmable control, this purpose-built technology platform supports trials of all complexities with ease.
-
Learn how eCOA helped to motivate patients and increased engagement around experiences outside of the clinical setting, which otherwise may have gone unmentioned.
-
This ebook describes how electronic clinical outcomes assessments (eCOA), mobile digital assessments, and other innovative data capture technologies are able to “meet patients where they are” in Parkinson’s Disease trials – with increasingly objective, sensitive, and continuous measures.
ECONSENT RESOURCES
-
Hear from industry experts on how they successfully combined agile eConsent technology with global regulatory expertise to increase enrollment rates and reduce both site and patient burden.
-
Watch this presentation and demonstration of One Home for Sites for the latest updates on how the industry is coming together — even competitors — to alleviate the technology burden on research sites.
-
Despite the rise of digital solutions in healthcare, paper consent forms are still common in today’s clinical trials. Unfortunately, these paper forms pose significant challenges in retaining the documentation of informed consent for centrally stored biospecimens.
EPRO RESOURCES
-
In the available blog post, learn about the importance of safety monitoring in clinical trials.
-
As trials continue to digitize, learn how connected sensors, COAs, PROs, and other forms of data will come together to form the evidence of tomorrow.
-
Find out how one company dedicated to producing innovative non-invasive chronic pain therapies was able to engage its patients in new ways.